Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioline D Henter

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Pharmacology & Therapeutics|May 5, 2023
The antidepressant actions of ketamine and its enantiomersJenessa N Johnston, Ioline D Henter, Carlos A Zarate
Harvard Review of Psychiatry|February 22, 2018
Glutamatergic Modulators in DepressionIoline D Henter, Rafael Teixeira de Sousa, Carlos A Zarate
Expert Opinion on Pharmacotherapy|July 12, 2021
Key considerations in the pharmacological management of treatment-resistant depressionMani Yavi, Ioline D Henter, Lawrence T Park, et al.
Dialogues in Clinical Neuroscience|November 3, 2009
The neurotrophic and neuroprotective effects of psychotropic agentsJoshua Hunsberger, Daniel R Austin, Ioline D Henter, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 13, 2013
Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Mark J Niciu, Ioline D Henter, Gerard Sanacora, et al.
JAMA Psychiatry|June 10, 2026
The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative ReviewGregory J Moore, Niranjan Bose, Ioline D Henter, et al.
Pharmacology, Biochemistry, and Behavior|October 6, 2011
Novel glutamatergic agents for major depressive disorder and bipolar disorderRodrigo Machado-Vieira, Lobna Ibrahim, Ioline D Henter, et al.
Bioethics|May 16, 2017
The Ethics of Clinical Trials Research in Severe Mood DisordersAllison C Nugent, Franklin G Miller, Ioline D Henter, et al.
CNS Spectrums|March 20, 2013
Defining anxious depression: a review of the literatureDawn F Ionescu, Mark J Niciu, Ioline D Henter, et al.
Discover Mental Health|May 5, 2022
Ketamine treatment for depression: a reviewMani Yavi, Holim Lee, Ioline D Henter, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Pharmacology & Therapeutics|May 5, 2023
The antidepressant actions of ketamine and its enantiomersJenessa N Johnston, Ioline D Henter, Carlos A Zarate
Harvard Review of Psychiatry|February 22, 2018
Glutamatergic Modulators in DepressionIoline D Henter, Rafael Teixeira de Sousa, Carlos A Zarate
Expert Opinion on Pharmacotherapy|July 12, 2021
Key considerations in the pharmacological management of treatment-resistant depressionMani Yavi, Ioline D Henter, Lawrence T Park, et al.
Dialogues in Clinical Neuroscience|November 3, 2009
The neurotrophic and neuroprotective effects of psychotropic agentsJoshua Hunsberger, Daniel R Austin, Ioline D Henter, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 13, 2013
Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Mark J Niciu, Ioline D Henter, Gerard Sanacora, et al.
JAMA Psychiatry|June 10, 2026
The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative ReviewGregory J Moore, Niranjan Bose, Ioline D Henter, et al.
Pharmacology, Biochemistry, and Behavior|October 6, 2011
Novel glutamatergic agents for major depressive disorder and bipolar disorderRodrigo Machado-Vieira, Lobna Ibrahim, Ioline D Henter, et al.
Bioethics|May 16, 2017
The Ethics of Clinical Trials Research in Severe Mood DisordersAllison C Nugent, Franklin G Miller, Ioline D Henter, et al.
CNS Spectrums|March 20, 2013
Defining anxious depression: a review of the literatureDawn F Ionescu, Mark J Niciu, Ioline D Henter, et al.
Discover Mental Health|May 5, 2022
Ketamine treatment for depression: a reviewMani Yavi, Holim Lee, Ioline D Henter, et al.
Pageof 8